Hydralazine-induced pericardial effusion

Mohammed Faisal Rahman; Muhammad Ajmal Panezai; Harold M Szerlip

doi:10.1080/08998280.2019.1613331

Hydralazine-induced pericardial effusion

Proc (Bayl Univ Med Cent). 2019 Jun 10;32(3):377-378. doi: 10.1080/08998280.2019.1613331. eCollection 2019 Jul.

Authors

Mohammed Faisal Rahman¹, Muhammad Ajmal Panezai¹, Harold M Szerlip¹

Affiliation

¹ Division of Nephrology, Baylor University Medical CenterDallasTexas.

Abstract

Drug-induced lupus (DIL) is due to an autoimmune reaction to a drug with an estimated incidence of 15,000 to 30,000 cases every year in the US. Hydralazine is a well-known offender. Antinuclear antibody (ANA) is present in most cases, though four cases of ANA-negative DIL have been reported. In this report, we present another case of ANA-negative DIL secondary to hydralazine.

Keywords: ANA-negative drug-induced lupus; hydralazine-induced lupus; pericardial effusion.

Publication types

Case Reports